local recombinant dna oversight mass biotech council series enforcement of the cambridge recombinant...
TRANSCRIPT
![Page 1: Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee](https://reader036.vdocuments.us/reader036/viewer/2022082710/56649e695503460f94b66d78/html5/thumbnails/1.jpg)
Local Recombinant DNA OversightMass Biotech Council Series
Enforcement of the Cambridge Recombinant DNA Technology Ordinance
Cambridge Biosafety Committee and Cambridge Public Health Department
July 9th, 2009
![Page 2: Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee](https://reader036.vdocuments.us/reader036/viewer/2022082710/56649e695503460f94b66d78/html5/thumbnails/2.jpg)
Local Recombinant DNA Oversight The Debate
1970s and the “Gene Scare” Asilomar Conference (1975) Cambridge debates gene splicing NIH develops biosafety standards Recombinant DNA Technology ordinance Other communities weigh in Amendments & Enforcement
![Page 3: Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee](https://reader036.vdocuments.us/reader036/viewer/2022082710/56649e695503460f94b66d78/html5/thumbnails/3.jpg)
Local Recombinant DNA OversightPublic Perception of Risk
Public health alarm has dissipated vs. 1970s Biotech as a clean, low-impact industry New focus of public concern:
• Biological/Chemical/Radiological terrorism • Pandemic flu• CDC-funded biocontainment labs (e.g. BU lab)
Public concern has also shifted to the applications of genetic technology
• GM foods• Gene therapy• Pharmaceutical safety, efficacy and value
![Page 4: Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee](https://reader036.vdocuments.us/reader036/viewer/2022082710/56649e695503460f94b66d78/html5/thumbnails/4.jpg)
Local Recombinant DNA Oversight Benefits of Cambridge/NIH Rules
Labs commit to public/worker safety via Institutional Biosafety Committees (IBCs): safe lab practices, training, containment
Companies and researchers get more predictable regulatory oversight; goodwill
Public gains accountability and transparency Public participation on these IBCs improves their
public credibility and informs residents
![Page 5: Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee](https://reader036.vdocuments.us/reader036/viewer/2022082710/56649e695503460f94b66d78/html5/thumbnails/5.jpg)
Local Recombinant DNA Oversight RDNA Permit Holder Responsibilities
Ensure compliance with NIH Guidelines and local rDNA regulation
Establish an IBC with full membership Appoint a Biosafety Officer (BSO) Ensure IBC has expertise in all reviewed work
and that members are trained Establish a medical surveillance program Report accidents to the NIH and local BOH Submit Annual Reports to NIH & BOH
![Page 6: Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee](https://reader036.vdocuments.us/reader036/viewer/2022082710/56649e695503460f94b66d78/html5/thumbnails/6.jpg)
Local Recombinant DNA OversightBiological Safety
… is achieved through a combination of containment principles operating at different levels:
Biological Containment• Environmental stability, growth factors, routes of
infection, attenuated strains, media requirements
Primary Containment• Safety cabinets, good microbiological practices, PPE
Secondary Containment• Barriers, decontamination, air flow, gas-tight (BSL3)
6
![Page 7: Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee](https://reader036.vdocuments.us/reader036/viewer/2022082710/56649e695503460f94b66d78/html5/thumbnails/7.jpg)
Local Recombinant DNA OversightBiosafety Levels
… describe a hierarchy of procedures, practices, equipment and lab design which achieve containment for the organism in question and the procedures to be used
Biosafety levels are ranked from 1- 4, BSL-4 being the most stringent. Cambridge does not allow BSL-4 labs under the rDNA ordinance.
Biosafety level assignment for a project is the result of a Comprehensive Risk Assessment based on procedures and the Risk Group for that agent ….
![Page 8: Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee](https://reader036.vdocuments.us/reader036/viewer/2022082710/56649e695503460f94b66d78/html5/thumbnails/8.jpg)
Local Recombinant DNA OversightRisk Group Levels
Risk Group 1: Agents that are not associated with disease in healthy adult humans
Risk Group 2: Agents that are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available
Risk Group 3: Agents associated with serious or lethal human disease for which preventive or therapeutic interventions may be available (high worker risk but low community risk)
Risk Group 4: Agents likely to cause serious lethal human disease for which preventive or therapeutic interventions are not usually available (high worker & community risk)
![Page 9: Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee](https://reader036.vdocuments.us/reader036/viewer/2022082710/56649e695503460f94b66d78/html5/thumbnails/9.jpg)
Pathogenicity
Infectious dose
Concentration
Environmental Stability
Transmission route
Host Range
Training & Skill Level
Vaccination Availability
Population Risk Factors
Medical Interventions
Disease Outcomes
Local Recombinant DNA OversightLab Worker vs. Community Risk
![Page 10: Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee](https://reader036.vdocuments.us/reader036/viewer/2022082710/56649e695503460f94b66d78/html5/thumbnails/10.jpg)
Local Recombinant DNA OversightLocal Enforcement Agencies
Cambridge Biosafety Committee (CBC)• CBC Meetings• IBC Representatives• Presentation to CBC• Laboratory Site Visits
Fire Department & LEPC• Chemical hygiene plans, flammables, hazmat
response, advanced 911 compatibility
![Page 11: Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee](https://reader036.vdocuments.us/reader036/viewer/2022082710/56649e695503460f94b66d78/html5/thumbnails/11.jpg)
Local Recombinant DNA OversightRequired Presentation to the CBC
Mission of Research Overview of rDNA Procedures & Vectors Floor Plans: BL level & Access Control Employee Medical Surveillance Permits received and pending (local, state) Service Contracts: Bio, Chem, Rad, Pests Submit Biosafety Manual & IBC Reps
![Page 12: Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee](https://reader036.vdocuments.us/reader036/viewer/2022082710/56649e695503460f94b66d78/html5/thumbnails/12.jpg)
Local Recombinant DNA Oversight Laboratory Site Visit
General Lab Hygiene Wastewater Treatment/Backflow
Prevention Signage Access Controls HVAC Systems/Air Balance/Filtration Biological/Chemical Waste Systems Ergonomics and Safety